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One of the most interesting and important problems in studies on the molecular switches of genes is their relationship with the differentiation of certain cell types during development. Hepatocytes are highly specialized epithelial cells responsible for the synthesis of many liver-specific proteins. The production of enzymes and proteins by the liver changes progressively during de- velopment. In the last 5 or 6 years, the regulations of expressions of these liver-specific genes have been studied extensively, a number of liver-specific or liver-enriched trans-acting factors have been characterized, and cDNAsof these factors have been cloned. These factors include HNF-1/LF-B1 , C/EBP and the related proteins (IL-6DBP/LAP), DBP, HNF-3 and HNF-4, which is probably identical with LF-A1 and HNF-2. Remarkably none of these factors seem to be restricted to the liver, suggesting that more subtle mechanisms underlie tissue-specific expression than just restricted expressions of transcription factors. Besides these positive factors, negative transcriptional factors are operative in the repression of certain genes. The actions of two or more factors in combination on multiple individual subdomainsupstream and downstreamof the transcription start site may be involved in the control of gene expressions in the liver and these gene expressions maybe balanced by positive and negative transcription factors.
/. Transcriptional Factors in Hepatocytes.
HNF-L
A nuclear protein from liver named hepatocyte nuclear factor la (HNF-1a, also referred to as HNF-1, LF-B1, and APF) was identified by virtue of its ability to form cell complexeswith a common sequence motif found in the 5'-flanking DNAof several liver-specific genes (Table I ). These genes include those for a and /3 fibrinogen, albumin, a-fetoprotein, transthyretin, a l-antitrypsin, aldolase B, pyruvate kinase, phosphoenol pyruvate carboxykinase, CYP2E1 , CYP2C6, and the hepatitis B virus large surface protein (1). Though HNF-1a is a relative of the homeodomainproteins, two characteristics distinguish it from the other membersof this family. First its DNA-binding domain contains a 21-amino acid insertion that is not found in any of the other homeodomains. Second, as inferred from the original recognition of the binding sequence as a center of dyad symmetry, HNF-1abinds to its recognition sequence as a dimer. After the finding of a HNF-1a relative (HNF-1/3, also called LF-B3 and VHNF-1), the nuclear protein previously called HNF-1 was renamed HNF-1a, HNF-1/3 was found to be a nuclear protein recognizing the same binding site as HNF-1a and was initially thought to be present only in dedifferentiated hepatoma cells. 
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But further studies demonstrated its expression in the liver, kidney and intestine. HNF-la and HNF-1/3 share dimerization and homeodomains, but their transactivation domains are different. The HNF-la and HNF-1/3 genes encode several isoforms of the gene products by the differential use of polyadenylation sites and by alternative splicing. The HNF-la and HNF-1/3 readily form heterodimers in vitro and the existence of such heterodimers in vivo has also been suggested. Possibly heterodimerization has implications in the regulatory network sustained by these factors.
Recently, a dimerization co factor of HNF-la (DCoH) was identified that did not bind to DNA, but selectively stabilized HNF-la dimers (2) . The formation of a stable tetrameric DCoH-HNF-lacomplex did not change the DNAbinding characteristics of HNF-la, but enhanced its transcriptional activation. C/EBPa mRNA is expressed abundantly in adipose tissue, liver and placenta. McKnight proposed that C /EBPa is a central regulator of energy metabolism. The liver specific genes whose transcriptions are knownto be controlled by C/EBPa are those for albumin, phosphoenol pyruvate carboxykinase, aldolase B, tyrosine aminotransferase, apolipoprotein B, CYP2C6, and carbamoyl phosphate synthetase. In adipose cells C/EBPa is known to play a role in differentiation and to control the expressions of adipose cell specific genes. C/EBP/3, also referred to as NF-IL6, IL-6DBP, LAP or CRP2, was found by independent groups. 1) NF-IL6 was found by Akira et al. (4) in studies on a nuclear factor that specifically binds to the interleukin-1-respon- have a DNA-binding domain and transcription activation domain, but the third product (LIP) binds to the specific DNAsequence without causing transcription activation. Thus, LIP homodimer and LIP-LAP heterodimer compete with LAPhomodimerfor the common cognate binding site and attenuate the transcription stimulation of LAP. LIP is also identical to SF-B (silencer factor B) that functions as a repressor of the glutathione transferase P gene.
By screening with the DNA-binding domain of the C /EBP gene as a probe, three genes, designated CRP1, CRP2 and CRP3, were isolated (5). CRP2 is identical to the protein described as C/EBP/3, and CRP3 is identical promoters with C/EBPbinding sites. These findings indicate a mechanismof gene regulation involving interaction between distinct transcription factor families. Transcription factor HNF-3 was first discovered during functional analysis of the transthyretin promoter and was subsequently shownto participate in the expressions of several other liver genes including a\-antitrypsin and aldolase B genes. The CDNAencoding HNF-3a was isolated and then two additional members of this family, HNF-3/3 and HNF-3f, were identified (6). Membersof the HNF-3 gene family in rodents show homology in both the DNA-binding domain and the amino-and carboxyl-termini. The HNF-3 genes also share homology with the Drosophila homeotic gene, fork head (fkh). All three mRNAs are expressed in the liver, and also in the small intestine at a low level, but not in the brain, spleen, or kidney. In addition to their expressions in the liver, HNF-3a and HNF-3/3 mRNAs are found in the lung, and HNF-3f mRNAis detectable in the testis. Additional HNF-3/fkh-related proteins are knownto be required for determination events during embryogenesis in Drosophila and Xenopus. Nine additional HNF-3/fkh homologue (HFH) clones were isolated from rodent tissue cDNAs.Manyof the HFH genes exhibit a tissue-restricted expression pattern and are transcribed in tissues other than the liver, including the brain, kidney, lung, and intestine.
Therefore, the HNF-3/fkh family is thought to play a role in tissue-specific gene regulation and development.
HNF-4.
HNF-4 is a protein enriched in liver extracts that binds to sites required for the transcription of the genes for transthyretin, apolipoprotein CIII and pyruvate ki- //. Transcriptional Factors and Liver Differentiation. In rodents, the liver develops from the gut endoderm on about day 9 of gestation. Between days ll and 15, the liver becomesrecognizable as a physical structure, at which time it serves primarily as a hematopoietic organ. Classical embryological approaches have indicated that extracellular factors play a prominent role in the development of the liver, and recent studies on other cell types have indicated that a limited number of transcription factors have effects on the differentiation of particular tissues. Most notably, pituitary-specific Pit/GHF-1 , muscle-specific MyoD, and erythroid-specific GATA-1 factors have critical effects on cell differentiation and autoregulatory loops play an important role in the onset of expression of these genes. Therefore, an important goal of studies on transcriptional regulators of cell-specific gene expression is to determine the mechanismsinvolved in initiating the program (or cascade) of development.
Analysis of pattern formation in the early Drosophila embryo has identified a number of developmental control genes that encode transcriptional regulators. The HNF-3 family is a vertebrate homolog to the Drosophila gene fork head, which does not fall into any of the known categories of transcription factors. Since fork head plays a critical role in embryogenesis of the gut, malpighian tubules and salivary gland, HNF-3 could have important early embryonic functions in mammals. HNF-3/3promoter analysis has suggested that an autoregulation mechanism is involved in the establishment of HNF-3expression. Studies on the role of HNF-4, a steroid receptor super family member, in embryogenesis in vertebrate have been developed by isolation of a Drosophila homolog to HNF-4, HNF-4 (D), by cross hybridization with a probe to rat HNF-4. Analysis of its expression in developing Drosophila embryos suggested an essential role of HNF-4in gut formation and organogenesis that may have been preserved during evolution from invertebrates to vertebrates; HNF-4(D) is expressed in developing Drosophila embryos in the mid-gut, fat bodies and malpighian tubules, which shows a striking similarity to its limited expression in the adult intestine, liver and kidney of the mouse. Recently, the expressions of HNF-3and HNF-4 in rodent embryos have been analyzed by an immunohistochemical technique and in situ hybridization using their cDNAs. Results have suggested that HNF-3 and HNF-4 play important roles in commitment of liver cells to differentiation and in their further differentiation. HNF-3is expressed in the embryonic endoderm and notochord as soon as these tissues emerge from Hensen's node. HNF-4is expressed at the onset of liver-gut development and then expression of HNF-la occurs. The order of expressions of HNF-4and HNF-la is consistent with the finding that HNF-4 is implicated as an essential positive regulator of HNF-la transcription.
Though HNF-3 also functions as a transactivator of the HNF-la promoter, studies on a variant hepatoma in which the liver phenotype is extinguished, and rat Fao x mouse fibroblast somatic hybrids in which liver gene expression is extinguished suggested that high-order loci regulate HNF-4 and HNF-la independently of the other hepatic trans-activators HNF-3 and C/EBP (Fig.  1) (8) . Furthermore, involvement of AP-1 in HNF-la expression has been suggested. Unlike in the case of the HNF-3/3 gene, there is no evidence for HNF-la promoter autoregulation. During retinoic acid-induced differentiation of F9 embryonic carcinoma cells, HNF-1/3 mRNA increases much faster than HNF-la mRNA. These independent regulatory mechanisms for HNF-la and -1/3 in F9 cells indicate that these proteins possess distinct developmental functions.
C/EBPa was first identified in liver, but later found to be expressed in several other tissues. C/EBPawas found to promote the terminal differentiation of adipocyte differentiation. It is also thought to be involved in hepatocyte differentiation from several observations. C /EBPa is detectable in liver before birth, while DBP protein does not appear until late stages of postnatal development. During liver regeneration, the expressions of DBPand C/EBP are rapidly down-regulated, suggesting that these factors may be involved in the proliferation control of hepatocytes. The C/EBPa promoter analysis suggested that C/EBPa and C/EBP-related proteins can transactivate the C/EBPa gene and that the Myc/Maxcomplex down-regulates its expression. The dramatic decrease of AFPgene expression during liver development might be due to decrease in c-fos/cjun proteins and significant increase of glucocorticoid after birth. Finally, the level of AFPmRNA in adult liver is influenced by a trans-acting locus on chromosome 15 termed raf by a posttranscriptional mechanism.
Expression in rat liver of serine dehydratase (SDH), which catalyzes degradation of serine to pyruvate and ammoniais a liver specific protein, but the developmental pattern of SDH expression differs from those of AFP and albumin. SDHmRNAwas not detected in fetal liver and SDH transcription is turned on after birth. We analyzed changes of nuclear proteins that bind to the SDHpromoter during development. Several DNAbinding regions were found to be commonto fetal and adult liver nuclear extracts and to contain Spl and NF-Ybinding sites. Twoother regions namedB and I were almost completely specific to the fetal liver nuclear extract (Fig. 2) . To determine the functions of regions B and I in transcription of the SDHgene, we fused the SDHpromoter with the chloramphenicol acetyl transferase (CAT) gene and performed CAT assays in primary cultures of fetal and adult hepatocytes.
The results showed that regions B and I function as negative elements in fetal hepatocytes, but are not functional in adult hepatocytes. Fromthese results, we proposed that the SDHgene in fetal liver is repressed by a negative factor(s) (10). Regions B and I contain homologous sequences to the binding site of GATA-factors, which recognize the GATA core sequence and contain zinc fingers. Binding of a nuclear protein to region B was inhibited by the presence of an oligonucleotide containing region I and the binding site of GATAfactors. This nuclear factor has not been identified, but a partial sequence corresponding to the DNAbinding domain of GATA-factors was cloned from rat hepatocytes by a method involving the reverse transcriptase-polymerase chain reaction. Possibly, a memberof the GATA-factor family is present not only in hematopoietic cells, but also in hepatocytes, and is involved in terminal differentiation of the liver.
Expression of the SDHgene may be controlled not only developmentally, but also during hepatocyte proliferation. In regenerating liver, the level of SDHmRNA decreases dramatically within 1 day after partially hepa- tectomy. Moreover, in primary cultures of adult rat hepatocytes, we demonstrated that SDHexpression decreased whenhepatocytes becamecompetent to growth factors and that conversely, the level of c-myc mRNA increased in hepatocytes cultured at low cell-density, a condition inducing competence for growth of hepatocytes. These results suggest that a trans-acting factor that becomesactive on Go to Gl entry of hepatocytes represses the SDHgene and activates the mycgene, or that SDHexpression can be controlled by regulatory hierarchies downstreamof either primary c-myc-response genes or other growth-related genes.
